IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 91 filers reported holding IRADIMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $497,840 | +4.0% | 11,330 | +4.1% | 0.00% | – |
Q1 2024 | $478,611 | -11.1% | 10,880 | -4.1% | 0.00% | – |
Q4 2023 | $538,310 | -3.6% | 11,340 | -9.9% | 0.00% | – |
Q3 2023 | $558,618 | -9.9% | 12,590 | -3.1% | 0.00% | – |
Q2 2023 | $620,143 | +18.5% | 12,990 | -2.3% | 0.00% | – |
Q1 2023 | $523,355 | +39.1% | 13,300 | 0.0% | 0.00% | – |
Q4 2022 | $376,257 | -1.5% | 13,300 | +4.7% | 0.00% | – |
Q3 2022 | $382,000 | -11.4% | 12,700 | 0.0% | 0.00% | – |
Q2 2022 | $431,000 | -21.9% | 12,700 | +3.3% | 0.00% | – |
Q1 2022 | $552,000 | -2.8% | 12,300 | 0.0% | 0.00% | – |
Q4 2021 | $568,000 | +37.5% | 12,300 | 0.0% | 0.00% | – |
Q3 2021 | $413,000 | +14.1% | 12,300 | 0.0% | 0.00% | – |
Q2 2021 | $362,000 | +16.0% | 12,300 | +1.7% | 0.00% | – |
Q1 2021 | $312,000 | +13.0% | 12,100 | 0.0% | 0.00% | – |
Q4 2020 | $276,000 | +6.6% | 12,100 | 0.0% | 0.00% | – |
Q3 2020 | $259,000 | -17.3% | 12,100 | -10.4% | 0.00% | – |
Q2 2020 | $313,000 | +48.3% | 13,500 | +36.4% | 0.00% | – |
Q1 2020 | $211,000 | – | 9,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |